Cell‐type‐specific excitatory and inhibitory circuits involving primary afferents in the substantia gelatinosa of the rat spinal dorsal horn in vitro

…, MH Rashid, M Sonohata, A Tamae… - The Journal of …, 2007 - Wiley Online Library
The substantia gelatinosa (SG) of the spinal dorsal horn shows significant morphological
heterogeneity and receives primary afferent input predominantly from Aδ‐ and C‐fibres. …

Direct inhibition of substantia gelatinosa neurones in the rat spinal cord by activation of dopamine D2‐like receptors

A Tamae, T Nakatsuka, K Koga, G Kato… - The Journal of …, 2005 - Wiley Online Library
Dopaminergic innervation of the spinal cord is largely derived from the brain. To understand
the cellular mechanisms of antinociception mediated by descending dopaminergic pathways…

Small cell carcinoma in the head and neck

…, M Masuda, M Matsuo, A Tamae… - Annals of Otology …, 2019 - journals.sagepub.com
Objectives: Small cell carcinomas in extrapulmonary sites (ESmCCs) are very rare. ESmCCs
originating in the head and neck account for approximately 10% of all ESmCCs, and there …

[HTML][HTML] PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma

…, K Hashimoto, M Matsuo, T Wakasaki, A Tamae… - Modern Pathology, 2021 - Elsevier
The antitumor efficacies of immune checkpoint inhibitors (ICIs) and the usefulness of potential
predictive markers such as programmed death-ligand 1 (PD-L1) expression, density of …

Inflammatory pseudotumor in head and neck

Y Segawa, R Yasumatsu, H Shiratsuchi, A Tamae… - Auris Nasus …, 2014 - Elsevier
Background Inflammatory pseudotumor (IPT) is a tumefactive lesion characterized by fibroblastic
proliferations and a prominent inflammatory component. It behaves as a locally benign …

Treatment efficacy of PD-1 inhibitor therapy in patients with recurrent and/or metastatic salivary gland carcinoma

…, Y Kuratomi, H Uryu, T Nakashima, A Tamae… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: The efficacy of programmed cell death 1 (PD-1) inhibitor therapy for patients
with recurrent and/or metastatic salivary gland carcinoma (R/M SGC) remains unclear. …

Syndrome of inappropriate antidiuretic hormone secretion in a case of olfactory neuroblastoma without anti-diuretic hormone immunoreactivity: A case report and …

T Nakano, J Motoshita, F Sawada, M Okabe, A Tamae… - Auris Nasus …, 2017 - Elsevier
Olfactory neuroblastoma (ONB) is a relatively rare nasal or paranasal malignant tumor. This
tumor is rarely accompanied by paraneoplastic syndromes such as syndrome of …

Diagnosis and following up of Ménière's disease using multifrequency tympanometry—Cutoff values and temporal changes in measurements

K Ishizu, A Tamae, K Kubo, T Yoshida, N Matsumoto… - Auris Nasus …, 2018 - Elsevier
Objective This study aimed to verify cutoff values for G width (the width of bimodal peaks for
the waveform obtained when measuring conductance at 2000 Hz) in Japanese individuals …

Retrospective study of cisplatin/carboplatin, 5-fluorouracil plus cetuximab (EXTREME) for advanced-stage salivary gland cancer

…, Y Kuratomi, H Uryu, T Nakashima, A Tamae… - in vivo, 2022 - iv.iiarjournals.org
Background/Aim: Surgery remains the standard treatment for salivary gland carcinoma (SGC).
Our study investigated the association between epidermal growth factor receptor (EGFR) …

Immune checkpoint inhibitors for nasopharyngeal carcinoma in a real-world setting in Japan

…, T Nakano, M Matsuo, T Takeuchi, M Taura, A Tamae… - in vivo, 2023 - iv.iiarjournals.org
Background/Aim: The advent of immune checkpoint inhibitor (ICI) treatment has transformed
the treatment of recurrent or metastatic head and neck cancer; however, nasopharyngeal …